A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients

Wellcome Trust Centre for Human Genetics, Nuffield Department of Surgery, University of Oxford, Headington, UK.
Nature Genetics (Impact Factor: 29.65). 06/1998; 19(3):301-302.

ABSTRACT It is generally assumed that the male:female (M:F) ratio in patients
with type 1 (insulin-dependent) diabetes mellitus (IDDM) is 1. A recent survey,
however, revealed that high incidence countries (mainly European) have a high
M:F ratio and low incidence ones (Asian and African) have a low M:F ratio1. We have now analysed the M:F ratio according to genotype at the
major locus, the major histocompatibility complex (MHC; IDDM1). There
are two main IDDM1 susceptibility haplotypes, HLA-DR3 and -DR4, which
are present in 95% of Caucasian cases2,
4. We report here
that in medium/high incidence Caucasian populations from the United States
of America, United Kingdom and Sardinia (1307 cases), the bias in male incidence
is largely restricted to the DR3/X category of patients (X DR4) with
a M:F ratio of 1.7 (P = 9.3 10−7), compared
with a ratio of 1.0 in the DR4/Y category (Y DR3). This is additional
evidence for significant heterogeneity between the aetiology of 'DR4-associated'
and 'DR3-associated' diabetes5,
We analysed linkage of type 1 diabetes to chromosome X, and as expected, most
of the linkage to Xp13−p11 was in the DR3/X affected sibpair families
(n = 97; peak multipoint MLS at DXS1068 = 3.5, P = 2.7
10−4; single point MLS = 4.5, P = 2.7
10−5). This is evidence for aetiological heterogeneity
at the IDDM1/MHC locus and, therefore, in the search for non-MHC loci
in type 1 diabetes, conditioning of linkage data by HLA type is advised.

Download full-text


Available from: Francesco Cucca, May 14, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Type 1 diabetes (T1D) is a genetically complex disorder of glucose homeostasis that results from the autoimmune destruction of the insulin-secreting cells of the pancreas. Two previous whole-genome scans for linkage to T1D in 187 and 356 families containing affected sib pairs (ASPs) yielded apparently conflicting results, despite partial overlap in the families analyzed. However, each of these studies individually lacked power to detect loci with locus-specific disease prevalence/sib-risk ratios (lambda(s)) <1.4. In the present study, a third genome scan was performed using a new collection of 225 multiplex families with T1D, and the data from all three of these genome scans were merged and analyzed jointly. The combined sample of 831 ASPs, all with both parents genotyped, provided 90% power to detect linkage for loci with lambda(s) = 1.3 at P=7.4x10(-4). Three chromosome regions were identified that showed significant evidence of linkage (P<2.2x10(-5); LOD scores >4), 6p21 (IDDM1), 11p15 (IDDM2), 16q22-q24, and four more that showed suggestive evidence (P<7.4x10(-4), LOD scores > or =2.2), 10p11 (IDDM10), 2q31 (IDDM7, IDDM12, and IDDM13), 6q21 (IDDM15), and 1q42. Exploratory analyses, taking into account the presence of specific high-risk HLA genotypes or affected sibs' ages at disease onset, provided evidence of linkage at several additional sites, including the putative IDDM8 locus on chromosome 6q27. Our results indicate that much of the difficulty in mapping T1D susceptibility genes results from inadequate sample sizes, and the results point to the value of future international collaborations to assemble and analyze much larger data sets for linkage in complex diseases.
    The American Journal of Human Genetics 10/2001; 69(4):820-30. DOI:10.1086/323501 · 10.99 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The development of insulin-dependent diabetes mellitus in both human and mouse is dependent on the interaction between genetic and environmental factors. The analysis of newly created NOD.C3H congenic strains for spontaneous and cyclophosphamide-induced diabetes has allowed the definition of three controlling genetic loci on mouse chromosome 6. A NOD-derived susceptibility allele at the Idd6 locus strongly influences the onset of diabetes in spontaneous diabetes. A NOD-derived resistance allele at the Idd19 locus affects the final diabetes incidence observed in both models, while a novel locus, provisionally termed Idd20, appears to control Idd19 in an epistatic manner. Decreased diabetes incidence is observed in CY-induced diabetes when Idd20 is homozygous for the C3H allele, while heterozygosity is associated with an increase in diabetes incidence. The Idd20, Idd19, and Idd6 candidate regions fall respectively within genetically defined intervals of 4, 7, and 4.5 cM on mouse chromosome 6. From our YAC contig, Idd6 would appear to localize within a ca. 1.5-Mb region on distal chromosome 6.
    Genomics 07/2001; 74(2):163-71. DOI:10.1006/geno.2001.6508 · 2.79 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Five novel peptides were identified in the brains of mice lacking active carboxypeptidase E, a neuropeptide-processing enzyme. These peptides are produced from a single precursor, termed proSAAS, which is present in human, mouse, and rat. ProSAAS mRNA is expressed primarily in brain and other neuroendocrine tissues (pituitary, adrenal, pancreas); within brain, the mRNA is broadly distributed among neurons. When expressed in AtT-20 cells, proSAAS is secreted via the regulated pathway and is also processed at paired-basic cleavage sites into smaller peptides. Overexpression of proSAAS in the AtT-20 cells substantially reduces the rate of processing of the endogenous prohormone proopiomelanocortin. Purified proSAAS inhibits prohormone convertase 1 activity with an IC(50) of 590 nM but does not inhibit prohormone convertase 2. Taken together, proSAAS may represent an endogenous inhibitor of prohormone convertase 1.
    The Journal of Neuroscience : The Official Journal of the Society for Neuroscience 02/2000; 20(2):639-48. · 6.75 Impact Factor